Hui-Yi Shiao

956 total citations
13 papers, 626 citations indexed

About

Hui-Yi Shiao is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Hui-Yi Shiao has authored 13 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Hui-Yi Shiao's work include Cancer therapeutics and mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Click Chemistry and Applications (2 papers). Hui-Yi Shiao is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Click Chemistry and Applications (2 papers). Hui-Yi Shiao collaborates with scholars based in Taiwan, India and Russia. Hui-Yi Shiao's co-authors include Hsing‐Pang Hsieh, Mohane Selvaraj Coumar, Chun‐Chen Liao, Yu-Sheng Chao, Wen‐Hsing Lin, Su‐Ying Wu, Chun-Wei Chang, Jian-Sung Wu, John Hsu and Yi-Yu Ke and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Hui-Yi Shiao

13 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui-Yi Shiao Taiwan	12	304	271	114	66	65	13	626
Guoyi Yan China	14	228 0.8×	332 1.2×	125 1.1×	56 0.8×	36 0.6×	39	608
Laura Maccari Italy	16	225 0.7×	337 1.2×	119 1.0×	41 0.6×	53 0.8×	24	662
Youlu Pan China	14	219 0.7×	262 1.0×	122 1.1×	77 1.2×	45 0.7×	38	609
Hengmiao Cheng United States	16	271 0.9×	352 1.3×	111 1.0×	56 0.8×	62 1.0×	30	623
Xin Zhai China	16	363 1.2×	369 1.4×	153 1.3×	122 1.8×	28 0.4×	66	695
Kiyoaki Sakata United States	14	320 1.1×	476 1.8×	166 1.5×	81 1.2×	102 1.6×	19	865
Maria Gabriella Brasca Italy	17	276 0.9×	345 1.3×	186 1.6×	61 0.9×	40 0.6×	28	663
Francesca Blasco Switzerland	14	222 0.7×	426 1.6×	145 1.3×	70 1.1×	36 0.6×	20	897
Rabah A.T. Serya Egypt	20	671 2.2×	429 1.6×	178 1.6×	67 1.0×	68 1.0×	38	1.0k
Eva Řezníčková Czechia	15	245 0.8×	259 1.0×	146 1.3×	85 1.3×	26 0.4×	44	541

Countries citing papers authored by Hui-Yi Shiao

Since Specialization

Citations

This map shows the geographic impact of Hui-Yi Shiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Yi Shiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Yi Shiao more than expected).

Fields of papers citing papers by Hui-Yi Shiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Yi Shiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Yi Shiao. The network helps show where Hui-Yi Shiao may publish in the future.

Co-authorship network of co-authors of Hui-Yi Shiao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Yi Shiao. A scholar is included among the top collaborators of Hui-Yi Shiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Yi Shiao. Hui-Yi Shiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lin, Shu‐Yu, Yi-Yu Ke, Wen‐Hsing Lin, et al.. (2019). Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 62(22). 10108–10123. 30 indexed citations

Shiao, Hui-Yi, et al.. (2019). Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers. 11(6). 739–739. 54 indexed citations

Singh, Vivek Kumar, Hsin-Huei Chang, Ching‐Chuan Kuo, et al.. (2016). Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors. Journal of Biomolecular Structure and Dynamics. 35(8). 1833–1848. 23 indexed citations

Ke, Yi-Yu, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.. (2014). Ligand efficiency based approach for efficient virtual screening of compound libraries. European Journal of Medicinal Chemistry. 83. 226–235. 14 indexed citations

Shiao, Hui-Yi, et al.. (2014). Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer. Expert Opinion on Investigational Drugs. 23(10). 1333–1348. 48 indexed citations

Sarvagalla, Sailu, Vivek Kumar Singh, Yi-Yu Ke, et al.. (2014). Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity. Journal of Computer-Aided Molecular Design. 29(1). 89–100. 38 indexed citations

Ke, Yi-Yu, Hui-Yi Shiao, Wen‐Hsing Lin, et al.. (2014). Facile Identification of Dual FLT3–Aurora A Inhibitors: A Computer‐Guided Drug Design Approach. ChemMedChem. 9(5). 953–961. 9 indexed citations

Shiao, Hui-Yi, et al.. (2014). Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery. MedChemComm. 5(9). 1266–1279. 19 indexed citations

Shiao, Hui-Yi, John Hsu, Jian-Sung Wu, et al.. (2013). Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors. Journal of Medicinal Chemistry. 56(10). 3889–3903. 109 indexed citations

10.

Coumar, Mohane Selvaraj, Yu-Shan Wu, Hui-Yi Shiao, et al.. (2011). Scaffold-Hopping Strategy: Synthesis and Biological Evaluation of 5,6-Fused Bicyclic Heteroaromatics To Identify Orally Bioavailable Anticancer Agents. Journal of Medicinal Chemistry. 54(8). 3076–3080. 86 indexed citations

11.

Ke, Yi-Yu, Hui-Yi Shiao, Hsing‐Pang Hsieh, et al.. (2011). Inhibition of HIV-1 Tat-Mediated Transcription by a Coumarin Derivative, BPRHIV001, through the Akt Pathway. Journal of Virology. 85(17). 9114–9126. 25 indexed citations

12.

Coumar, Mohane Selvaraj, Jim‐Tong Horng, Hui-Yi Shiao, et al.. (2010). Anti-Influenza Drug Discovery: Structure−Activity Relationship and Mechanistic Insight into Novel Angelicin Derivatives. Journal of Medicinal Chemistry. 53(4). 1519–1533. 138 indexed citations

13.

Shiao, Hui-Yi, Hsing‐Pang Hsieh, & Chun‐Chen Liao. (2008). First Total Syntheses of (±)-Annuionone B and (±)-Tanarifuranonol. Organic Letters. 10(3). 449–452. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact